(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Biochemical analysis of BRO-1-RNT-1 interaction. (A) EMSA
showing BRO-1-RNT-1 interaction. Lanes 1 and 4: GST-RNT-1 Runt domain (GST-RD)
purified protein (20 ng) incubated with Runx consensus DNA binding site probe
AACCGCA (10 fmol). A weak band shift can be observed (arrow) that is abolished
by the addition of 30x (300 fmol); lane 2) or 100x (1 pmol; lane
3) of cold WT competitor. However, a mutated version of the competitor probe
(AATCGAA), at 30x (lane 5) or 100x (lane 6),
is also able to abolish RNT-1-DNA binding. The addition of purified BRO-1
protein (100 ng) to the reaction (lanes 7 and 10) causes the GST-RD band to be
super-shifted and enhanced. These band shifts are still abolished by a cold WT
competitor probe at 30x (lane 8) or 100x (lane 9), but this time
the mutated competitor probe, added at 30x (lane 11) or 100x (lane
12), is unable to diminish RNT-1-DNA binding. (B) EMSA showing the
RNT-1 e1241 point mutant I112K does not interact with
BRO-1. Lane 1, Runx consensus DNA binding site probe incubated with purified
BRO-1 (1000 ng). No band shift is observed indicating that no non-specific DNA
binding is occurring. Lane 2, 20 ng WT GST-RD incubated with Runx probe
showing same band shift as in A. Increasing amounts of BRO-1 (lanes 3 and 4,
10 ng and 100 ng, respectively) causes the RNT-1-DNA band shift to be
supershifted and enhanced as expected. Lane 5, 40 ng of GST-e1241 (Runt domain
of RNT-1 containing the I112K mutation found in the e1241
rnt-1 allele) incubated with Runx probe. Incubation with increasing
amounts of BRO-1 (lanes 6 and 7, 10 ng and 100 ng, respectively) has no effect
on the band shift, indicating that I112K RNT-1 does not interact
with BRO-1. (C) RUBY experiment showing direct interaction between
BRO-1 and RNT-1 in mammalian cells. (i,iii,v) Fluorescence images. (ii,iv,vi)
Merged fluorescence and phase contrast images. (i,ii) Cells expressing a
RUBY-BRO-1 fusion. (iii,iv) Cells expressing a monomeric RUBY-RNT-1RD (Runt
domain of RNT-1) fusion. (v,vi) Cells co-expressing both RUBY-BRO-1 and
RUBY-RNT-1RD fusions.